Bank Julius Baer & Co. Ltd, Zurich Oncocyte Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.38 - $2.63 $372,598 - $710,097	-269,999 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$1.2 - $1.89 $143,998 - $226,798	119,999 Added 80.0%	269,999 $375,000
Q2 2020 Aug 12, 2020	BUY	$1.91 - $3.45 $286,500 - $517,500	150,000 New	150,000 $286,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $318M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.